Similarly, inhibition of GLP and G9a using BIX-01294 increased type I interferon and Imatinib responsiveness in several Chronic Myeloid Leukemia (CML) cell lines [140]. Here, EHMT2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.